Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging

阶段(地层学) 癌症 AJCC分段系统 医学 癌症分期 监测、流行病学和最终结果 流行病学 腺癌 肿瘤科 结直肠癌 癌症登记处 内科学 外科 登台系统 古生物学 生物
作者
J. B. O'Connell,Melinda A. Maggard,Clifford Y. Ko
出处
期刊:Journal of the National Cancer Institute [Oxford University Press]
卷期号:96 (19): 1420-1425 被引量:1557
标识
DOI:10.1093/jnci/djh275
摘要

Background: The recently revised American Joint Committee on Cancer (AJCC) sixth edition cancer staging system increased the stratification within colon cancer stages II and III defined by the AJCC fifth edition system. Using nationally representative Surveillance, Epidemiology, and End Results (SEER) data, we compared survival rates associated with colon cancer stages defined according to both AJCC systems. Methods: Using SEER data (from January 1, 1991, through December 31, 2000), we identified 119 363 patients with colon adenocarcinoma and included all patients in two analyses by stages defined by AJCC fifth and sixth edition systems. Tumors were stratified by SEER’s “extent of disease” and “number of positive [lymph] nodes” coding schemes. Kaplan–Meier analyses were used to compare overall and stage-specific 5-year survival. All statistical tests were two-sided. Results: Overall 5-year survival was 65.2%. According to stages defined by the AJCC fifth edition system, 5-year stage-specific survivals were 93.2% for stage I, 82.5% for stage II, 59.5% for stage III, and 8.1% for stage IV. According to stages defined by the AJCC sixth edition system, 5-year stage-specific survivals were 93.2% for stage I, 84.7% for stage IIa, 72.2% for stage IIb, 83.4% for stage IIIa, 64.1% for stage IIIb, 44.3% for stage IIIc, and 8.1% for stage IV. Under the sixth edition system, 5-year survival was statistically significantly better for patients with stage IIIa colon cancer (83.4%) than for patients with stage IIb disease (72.2%) (P<.001). Conclusions: The AJCC sixth edition system for colon cancer stratifies survival more distinctly than the fifth edition system by providing more substages. The association of stage IIIa colon cancer with statistically significantly better survival than stage IIb in the new system may reflect current clinical practice, in which stage III patients receive chemotherapy but stage II patients generally do not.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
空山新雨发布了新的文献求助10
1秒前
WSYang完成签到,获得积分10
1秒前
2秒前
阎梦凡完成签到,获得积分10
3秒前
爱炸鸡也爱烧烤完成签到 ,获得积分10
3秒前
卡卡完成签到 ,获得积分10
4秒前
yang完成签到,获得积分20
6秒前
Ava应助城寨招牌叉烧饭采纳,获得10
8秒前
8秒前
halosheep发布了新的文献求助30
8秒前
10秒前
封尘逸动发布了新的文献求助10
11秒前
yudiao完成签到,获得积分20
12秒前
14秒前
搜集达人应助yang采纳,获得10
16秒前
awwwer发布了新的文献求助10
18秒前
Noah完成签到,获得积分10
20秒前
机灵的蚂蚁完成签到,获得积分10
21秒前
锦诗完成签到,获得积分10
21秒前
yoyo20012623完成签到,获得积分10
23秒前
23秒前
25秒前
25秒前
高高的茉莉完成签到,获得积分10
25秒前
量子星尘发布了新的文献求助10
26秒前
27秒前
27秒前
Arpeggione关注了科研通微信公众号
28秒前
28秒前
吴仁杰发布了新的文献求助10
29秒前
niuma发布了新的文献求助20
29秒前
CY发布了新的文献求助10
29秒前
30秒前
搞怪世德发布了新的文献求助10
30秒前
shinysparrow举报慕明花开求助涉嫌违规
30秒前
31秒前
如泣草芥完成签到,获得积分0
31秒前
李晨晨发布了新的文献求助20
32秒前
33秒前
33秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 310
The Moiseyev Dance Company Tours America: "Wholesome" Comfort during a Cold War 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3979916
求助须知:如何正确求助?哪些是违规求助? 3524003
关于积分的说明 11219349
捐赠科研通 3261424
什么是DOI,文献DOI怎么找? 1800654
邀请新用户注册赠送积分活动 879239
科研通“疑难数据库(出版商)”最低求助积分说明 807214